Society guideline links: Vasculitis

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Glomerular disease in adults" and "Society guideline links: Urticarial vasculitis".)

International

●Revised international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis (2017)

Canada

●Canadian Vasculitis Research Network (CanVasc): Recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitides, update (2020)

United States

●American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology (EULAR): Classification criteria for eosinophilic granulomatosis with polyangiitis (2022)

●ACR/EULAR: Classification criteria for granulomatosis with polyangiitis (2022)

●ACR/EULAR: Classification criteria for microscopic polyangiitis (2022)

●American Academy of Pediatrics (AAP): Red Book – Kawasaki disease (2021)

●American College of Radiology (ACR): ACR Appropriateness Criteria on noncerebral vasculitis (2021)

●ACR/Vasculitis Foundation (VF): Guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis (2021)

●ACR/VF: Guideline for the management of giant cell arteritis and Takayasu arteritis (2021)

●ACR/VF: Guideline for the management of polyarteritis nodosa (2021)

●Childhood Arthritis and Rheumatology Research Alliance (CARRA): Consensus treatment plans for severe pediatric antineutrophil cytoplasmic antibody-associated vasculitis (2021)

●American Heart Association (AHA): Scientific statement on the diagnosis, treatment, and long-term management of Kawasaki disease (2017)

Europe

●American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology (EULAR): Classification criteria for eosinophilic granulomatosis with polyangiitis (2022)

●ACR/EULAR: Classification criteria for granulomatosis with polyangiitis (2022)

●ACR/EULAR: Classification criteria for microscopic polyangiitis (2022)

●EULAR: Recommendations for the management of large vessel vasculitis, 2018 update (published 2020)

●Single Hub and Access point for paediatric Rheumatology in Europe (SHARE): European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis (2019)

●SHARE: European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides (2019)

●EULAR: Recommendations for the use of imaging in large vessel vasculitis in clinical practice (2018)

●EULAR/European Renal Association-European Dialysis and Transplant Association (ERA-EDTA): Recommendations for the management of ANCA-associated vasculitis (2016)

●Society for Cardiovascular Pathology (SCVP) and Association for European Cardiovascular Pathology (AECVP): Consensus statement on surgical pathology of the aorta – Inflammatory diseases (2015)

United Kingdom

●British Society for Rheumatology (BSR) and British Health Professionals in Rheumatology (BHPR): Guideline for the management of adults with ANCA-associated vasculitis (2014)

●Oxford Specialist Handbooks in Paediatrics: Paediatric Rheumatology – Systemic diseases: The classification of paediatric vasculitis (2012)

Japan

●[In English] Japanese Society of Pediatric Cardiology and Cardiac Surgery (JSPCCS): Guidelines for medical treatment of acute Kawasaki disease, 2020 revised version (published 2021)

●[In English] Japanese Circulation Society (JCS)/Japanese Society for Cardiovascular Surgery (JSCS): Guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease (2020)

●[In English] JCS: Guideline on management of vasculitis syndrome, 2017 (published 2020)

●[In English] Japanese Dermatological Association (JDA): Wound, pressure ulcer and burn guidelines ─ Guidelines for the management of connective tissue disease/vasculitis-associated skin ulcers (2020)

●[In English] Japan Research Committee for Intractable Vasculitis: 2017 clinical practice guidelines for the management of ANCA-associated vasculitis (published 2018)

●[In Japanese] Japan Research Committee for Intractable Vasculitis: Clinical practice guidelines for the management of ANCA-associated vasculitis (2017)

●[In English] JDA: Outline of guidelines for the management of vasculitis and vascular disorders in Japan, 2016 revised edition (published 2017)

●[In Japanese] JDA: Clinical practice guideline for the management of vasculitis and vascular disorders, 2016 revised edition (published 2017)

●[In Japanese] JDA: The wound/burn guidelines – Guidelines for the management of skin ulcers associated with connective tissue disease/vasculitis (2017)